AAAAAA

   
Results: 1-24 |
Results: 24
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120
Authors: Jeffs, SA Gorny, MK Williams, C Revesz, K Volsky, B Burda, S Wang, XH Bandres, J Zolla-Pazner, S Holmes, H
Citation: Sa. Jeffs et al., Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120, IMMUNOL LET, 79(3), 2001, pp. 209-213
Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1
Authors: York, J Follis, KE Trahey, M Nyambi, PN Zolla-Pazner, S Nunberg, JH
Citation: J. York et al., Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1, J VIROLOGY, 75(6), 2001, pp. 2741-2752
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120
Authors: Hioe, CE Tuen, M Chien, PC Jones, G Ratto-Kim, S Norris, PJ Moretto, WJ Nixon, DF Gorny, MK Zolla-Pazner, S
Citation: Ce. Hioe et al., Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120, J VIROLOGY, 75(22), 2001, pp. 10950-10957
Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6
Authors: Verrier, F Nadas, A Gorny, MK Zolla-Pazner, S
Citation: F. Verrier et al., Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6, J VIROLOGY, 75(19), 2001, pp. 9177-9186
Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type I virions of different genetic clades
Authors: Mbah, HA Burda, S Gorny, MK Williams, C Revesz, K Zolla-Pazner, S Nyambi, PN
Citation: Ha. Mbah et al., Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type I virions of different genetic clades, J VIROLOGY, 75(16), 2001, pp. 7785-7788
Polymerase chain reaction-based assay for antibody-mediated neutralizationof HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay
Authors: Achkar, JM Wang, XH Nyambi, P Gorny, MK Zolla-Pazner, S Bandres, JC
Citation: Jm. Achkar et al., Polymerase chain reaction-based assay for antibody-mediated neutralizationof HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay, J ACQ IMM D, 24(3), 2000, pp. 203-210
Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis
Authors: Samanich, KM Keen, MA Vissa, VD Harder, JD Spencer, JS Belisle, JT Zolla-Pazner, S Laal, S
Citation: Km. Samanich et al., Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis, CL DIAG LAB, 7(4), 2000, pp. 662-668
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4(+) T cell-proliferative responses to glycoprotein 120
Authors: Hioe, CE Jones, GJ Rees, AD Ratto-Kim, S Birx, D Munz, C Gorny, MK Tuen, M Zolla-Pazner, S
Citation: Ce. Hioe et al., Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4(+) T cell-proliferative responses to glycoprotein 120, AIDS RES H, 16(9), 2000, pp. 893-905
HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) classII in the virion envelope
Authors: Lallos, LB Cecilia, D Fenyo, EM Laal, S Zolla-Pazner, S
Citation: Lb. Lallos et al., HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) classII in the virion envelope, AIDS, 14(11), 2000, pp. 1523-1531
Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41
Authors: Taniguchi, Y Zolla-Pazner, S Xu, YN Zhang, XY Takeda, S Hattori, T
Citation: Y. Taniguchi et al., Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41, VIROLOGY, 273(2), 2000, pp. 333-340
Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins
Authors: Gorny, MK VanCott, TC Williams, C Revesz, K Zolla-Pazner, S
Citation: Mk. Gorny et al., Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins, VIROLOGY, 267(2), 2000, pp. 220-228
A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex
Authors: Park, EJ Gorny, MK Zolla-Pazner, S Quinnan, GV
Citation: Ej. Park et al., A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex, J VIROLOGY, 74(9), 2000, pp. 4183-4191
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes
Authors: Nyambi, PN Nadas, A Mbah, HA Burda, S Williams, C Gorny, MK Zolla-Pazner, S
Citation: Pn. Nyambi et al., Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes, J VIROLOGY, 74(22), 2000, pp. 10670-10680
A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates
Authors: Verrier, F Burda, S Belshe, R Duliege, AM Excler, JL Klein, M Zolla-Pazner, S
Citation: F. Verrier et al., A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates, J VIROLOGY, 74(21), 2000, pp. 10025-10033
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M
Authors: Nyambi, PN Mbah, HA Burda, S Williams, C Gorny, MK Nadas, A Zolla-Pazner, S
Citation: Pn. Nyambi et al., Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M, J VIROLOGY, 74(15), 2000, pp. 7096-7107
Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiencyvirus type 1 gp41
Authors: Gorny, MK Zolla-Pazner, S
Citation: Mk. Gorny et S. Zolla-pazner, Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiencyvirus type 1 gp41, J VIROLOGY, 74(13), 2000, pp. 6186-6192
Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A
Authors: Hochleitner, EO Gorny, MK Zolla-Pazner, S Tomer, KB
Citation: Eo. Hochleitner et al., Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A, J IMMUNOL, 164(8), 2000, pp. 4156-4161
Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1
Authors: Hioe, CE Hildreth, JEK Zolla-Pazner, S
Citation: Ce. Hioe et al., Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1, AIDS RES H, 15(6), 1999, pp. 523-531
Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope
Authors: Lallos, LB Laal, S Hoxie, JA Zolla-Pazner, S Bandres, JC
Citation: Lb. Lallos et al., Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope, AIDS RES H, 15(10), 1999, pp. 895-897
The implications of antigenic diversity for vaccine development
Authors: Zolla-Pazner, S Gomy, MK Nyambi, PN
Citation: S. Zolla-pazner et al., The implications of antigenic diversity for vaccine development, IMMUNOL LET, 66(1-3), 1999, pp. 159-164
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV
Authors: Zolla-Pazner, S Gorny, MK Nyambi, PN VanCott, TC Nadas, A
Citation: S. Zolla-pazner et al., Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV, J VIROLOGY, 73(5), 1999, pp. 4042-4051
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins
Authors: Gigler, A Dorsch, S Hemauer, A Williams, C Kim, S Young, NS Zolla-Pazner, S Wolf, H Gorny, MK Modrow, S
Citation: A. Gigler et al., Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins, J VIROLOGY, 73(3), 1999, pp. 1974-1979
A longitudinal study of neutralizing antibodies and disease progression inHIV-1-infected subjects
Authors: Cecilia, D Kleeberger, C Munoz, A Giorgi, JV Zolla-Pazner, S
Citation: D. Cecilia et al., A longitudinal study of neutralizing antibodies and disease progression inHIV-1-infected subjects, J INFEC DIS, 179(6), 1999, pp. 1365-1374
Early-stage HIV infection and hepatitis C virus infection are associated with elevated serum porphyrin levels
Authors: Lim, HW Pereira, A Sassa, S Kim, M Zolla-Pazner, S
Citation: Hw. Lim et al., Early-stage HIV infection and hepatitis C virus infection are associated with elevated serum porphyrin levels, J AM ACAD D, 39(6), 1998, pp. 956-959
Risultati: 1-24 |